Riso Kyoiku Co., Ltd. (4714) AI Stock Analysis

• Market Cap: ¥34.84B
• Dividend Yield: 5%
• Average Volume (3M): 532.96K
• Price to Earnings (P/E): 24.8
• Beta (1Y): 0.68
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: JP
• Employees: 1,119
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Education & Training Services
• EPS (TTM): 3.36
• Shares Outstanding: 171,806,150
• 10 Day Avg. Volume: 610,630
• 30 Day Avg. Volume: 532,956
• PEG Ratio: -9.39
• Price to Book (P/B): 3.53
• Price to Sales (P/S): 1.27
• P/FCF Ratio: 23.40
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 71 Outperform
• Price Target: ¥222.00 ▲(9.36% Upside)

The score is driven primarily by strong financial fundamentals, led by an exceptionally conservative balance sheet and solid profitability, offset by inconsistent cash-flow conversion. Technicals are neutral-to-weak due to being below longer-term moving averages and a negative MACD, while valuation is supported by a ~5% dividend yield but tempered by a ~24 P/E.

Riso Kyoiku Co., Ltd. Business Overview & Revenue Model

Company Description

Riso Kyoiku Co., Ltd. operates TOMAS private study Juku schools for elementary, and junior and senior high school students in Japan. The company also operates MEDIC TOMAS private study Juku schools that specialize in preparation for medical school exams. It operates 64 TOMAS private study Juku schools. Riso Kyoiku Co., Ltd. was founded in 1985 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Riso Kyoiku Co., Ltd. Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	33.60B	33.39B	32.22B	31.49B	30.01B	25.20B
Gross Profit	8.87B	9.08B	8.52B	8.51B	8.46B	6.11B
EBITDA	2.78B	3.14B	2.87B	2.73B	3.40B	1.41B
Net Income	1.61B	1.74B	1.66B	1.49B	2.39B	555.23M
Balance Sheet
Total Assets	20.36B	22.09B	18.26B	18.25B	19.05B	13.94B
Cash, Cash Equivalents and Short-Term Investments	7.80B	8.95B	5.46B	7.31B	8.01B	3.96B
Total Debt	89.54M	12.94M	0.00	1.68M	3.90M	6.09M
Total Liabilities	10.39B	10.02B	9.60B	8.90B	8.53B	7.37B
Stockholders Equity	9.97B	12.07B	8.65B	9.22B	10.51B	6.58B
Cash Flow
Free Cash Flow	0.00	1.82B	835.18M	2.02B	2.84B	-401.89M
Operating Cash Flow	0.00	2.45B	1.65B	2.78B	3.61B	-36.38M
Investing Cash Flow	0.00	-801.30M	-1.03B	-1.02B	-1.01B	-655.55M
Financing Cash Flow	0.00	1.84B	-2.47B	-2.47B	1.45B	-182.30M

Riso Kyoiku Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
9470	75 Outperform	¥48.39B	12.85	―	2.28%	7.30%	60.93%
9769	72 Outperform	¥26.82B	15.28	―	4.01%	-1.18%	-12.01%
9733	72 Outperform	¥75.53B	20.20	―	3.98%	15.54%	67.62%
4714	71 Outperform	¥34.84B	24.76	―	5.00%	―	―
4718	70 Outperform	¥43.52B	16.83	―	2.56%	7.41%	22.70%
9795	70 Outperform	¥40.21B	14.26	―	3.55%	4.95%	9.43%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%

Riso Kyoiku Co., Ltd. Corporate Events

Riso Kyoiku Reports Mixed Second Quarter Results Amid Strategic Investments

Riso Kyoiku Group Corporation reported a slight increase in net sales for the second quarter of the fiscal year ending February 2026, despite varied performance across its segments. The company experienced a decline in profit due to increased personnel and recruitment costs, as well as higher rent expenses. These investments are seen as foundational for future growth and improved service quality, with a focus on enhancing productivity and cost efficiency to recover profitability.

Riso Kyoiku Reports Mixed Financial Results for H1 2025

Riso Kyoiku Group Corporation reported its consolidated financial results for the six months ended August 31, 2025, showing a slight increase in net sales by 1.1% compared to the previous year. However, the company faced significant declines in operating profit, ordinary profit, and profit attributable to owners of the parent, with decreases of 46.6%, 45.1%, and 38.2% respectively. Despite these challenges, the company maintains its forecast for the fiscal year ending February 28, 2026, with expected growth in net sales and profits, indicating a positive outlook for the future.